Pulmonary emphysema is a chronic lung condition that damages the air sacs and makes breathing hard. People with pulmonary emphysema often feel short of breath, have a long-lasting cough, and get tired with light activity. It tends to progress over years, most often in adults with a history of smoking or long-term exposure to air pollutants. Treatment focuses on inhalers, pulmonary rehab, quitting smoking, and oxygen when needed, and surgeries are reserved for select cases. The outlook varies, but many people live long and full lives with good care and risk-factor control.
Overview
Pulmonary emphysemaSymptoms
Early symptoms of pulmonary emphysema include breathlessness on stairs and a persistent cough with mucus. Over time, many develop wheezing, chest tightness, fatigue, and more frequent chest infections, with shortness of breath worsening during routine activities and sometimes at rest.
Outlook and prognosis
Many living with pulmonary emphysema can stay active for years with treatment, pulmonary rehab, and quitting smoking. Lung function usually declines gradually, but the pace varies. Vaccinations, prompt care for infections, oxygen when needed, and nutrition support improve quality of life.
Causes and risk factors
Pulmonary emphysema most often stems from long-term cigarette smoking; secondhand smoke also raises risk. Other factors include occupational dusts and chemical fumes, indoor/outdoor air pollution, and older age. A genetic form, alpha‑1 antitrypsin deficiency, increases susceptibility, especially in smokers.
Genetic influences
Genetics play a modest role in pulmonary emphysema. The strongest known cause is smoking, but rare inherited changes—most notably alpha-1 antitrypsin deficiency—can trigger early emphysema or worsen disease, especially without protection from smoke and occupational exposures.
Diagnosis
Doctors diagnose pulmonary emphysema using your history and exam, spirometry to check airflow, and imaging—often chest CT. They may add pulse oximetry or arterial blood gases, and sometimes alpha‑1 antitrypsin testing.
Treatment and drugs
Treatment for pulmonary emphysema focuses on easing breathing, protecting lung function, and preventing flare-ups. Care often includes inhalers, pulmonary rehab, vaccines, oxygen when needed, and support to stop smoking; some benefit from airway valves or surgery in select cases. Regular check-ins help tailor medicines, activity plans, and flare-up action steps.
Symptoms
Climbing stairs or carrying groceries can start to feel harder, with a breathless, tight feeling that lingers. You might notice small changes at first—early symptoms of pulmonary emphysema often show up as getting winded on stairs or during a brisk walk. As the condition progresses, breathing out becomes tougher, and everyday activity can take more effort. Pulmonary emphysema can also bring on cough, wheeze, and flare-ups after colds or exposure to smoke or pollution.
In pulmonary emphysema, feeling winded during chores, walking uphill, or carrying bags is common and tends to progress over time. What once felt effortless can start to require more energy or focus. It may improve when you rest but returns with activity.
A lingering, often dry cough can develop, sometimes with small amounts of clear mucus. In pulmonary emphysema, it may be worse in the morning or with smoke, cold air, or respiratory infections. A healthcare professional can help sort out what’s typical aging and what warrants a closer look.
With pulmonary emphysema, a whistling or squeaky sound when you breathe out can happen, especially during colds or at night. Clinicians call this wheeze, which means noisy breathing due to narrowed airways. It can come and go, and may flare with exercise or allergens.
Some feel a pressure or band-like tightness in the chest, especially with exertion. It can be uncomfortable but not always painful, and usually eases with rest.
How people usually first notice Pulmonary emphysema?
Many people first notice pulmonary emphysema when everyday breaths start to feel harder, especially during a brisk walk or climbing stairs, and a long-standing “smoker’s cough” lingers with more mucus than before. Over time, you may find wheezing, chest tightness, or frequent chest infections that take longer to clear, prompting a visit where a clinician hears reduced breath sounds and confirms airflow limits with spirometry. For many, the first signs of pulmonary emphysema show up as gradually worsening shortness of breath and exercise intolerance rather than sudden symptoms.
Types of Pulmonary emphysema
Pulmonary emphysema has a few well-recognized patterns that influence where damage shows up in the lungs and how early symptoms of emphysema feel day to day. Clinicians often describe them in these categories: some start in the center of the air sacs, others affect the edges first, and a rare inherited form ties to a specific protein shortage. These patterns can shape breathlessness during walks, how often cough or infections flare, and how quickly lung function changes over time. Not everyone will experience every type.
Centrilobular (CE)
Damage starts in the central parts of the air sacs, usually in the upper lungs. People with this type often have a long smoking history and notice breathlessness on hills or stairs. Cough with mucus and flare‑ups can be more common.
Panlobular (PLE)
Damage involves the entire air sac unit more evenly, often in the lower lungs. Breathlessness can appear earlier and progress steadily, even with less cough. Oxygen levels may drop sooner during activity.
Paraseptal (PSE)
Damage affects the outer edges of the lungs near the pleura. Many feel fewer daily symptoms at first but can develop sudden chest pain from a collapsed lung. Exercise breathlessness may be mild until later.
Alpha‑1 antitrypsin
This inherited variant can cause panlobular emphysema at a younger age, even without much smoking. People may notice early breathlessness, wheeze, or frequent chest infections. Family members sometimes have liver issues tied to the same condition.
Bullous emphysema
Large air pockets (bullae) replace normal lung tissue and compress healthier areas. Some have few symptoms until a bulla ruptures and causes a collapsed lung. Others feel limited by shortness of breath out of proportion to standard tests.
Mixed patterns
More than one pattern can occur in the same lungs, especially in long‑term smokers. Symptoms may blend, with both exertional breathlessness and mucus‑heavy cough. Imaging helps clarify types of pulmonary emphysema in these cases.
What genetics can tell you about symptoms
Some people with alpha-1 antitrypsin (AAT) gene variants, especially ZZ or SZ types, develop emphysema earlier, with breathlessness, wheezing, and frequent chest infections. These variants reduce AAT, a lung-protecting protein, letting inflammation damage air sacs.
Causes and risk factors
The main risk factor for pulmonary emphysema is long-term breathing of irritants, especially cigarette smoke.
Secondhand smoke and workplace dust or chemical fumes also raise risk.
Older age and a history of asthma or frequent lung infections raise risk, and an inherited condition called alpha-1 antitrypsin deficiency can too.
Air pollution and heavy indoor smoke from wood or coal can harm the lungs over time.
Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental and biological risk factors
Pulmonary emphysema makes breathing progressively harder by damaging the lungs’ tiny air sacs. Doctors often group risks into internal (biological) and external (environmental). These influences can come from the air you breathe or how your lungs develop and heal. They also help explain who develops the condition and when early symptoms of pulmonary emphysema may show up.
Breathing tobacco smoke in shared spaces can irritate and inflame the lungs. Long-term exposure raises the chance of pulmonary emphysema. Higher levels of exposure can lead to more damage.
Dust from mining, construction, or grain and chemical vapors can injure airways. Repeated exposure over years increases pulmonary emphysema risk. Irritation and inflammation can accelerate damage to air sacs.
Fine particles and ozone can reach deep into the lungs. High-pollution days and long-term exposure are linked with worse lung function and emphysema changes. People with existing lung disease may feel effects sooner.
Smoke from wood, coal, or crop residues used for cooking or heating can harm the lungs. Prolonged exposure, especially in poorly vented rooms, is tied to pulmonary emphysema. Children and older adults in the home can also be affected.
Genetic risk factors
Pulmonary emphysema can sometimes run in families, especially when certain protective lung proteins are lacking or the lung’s supporting fibers are altered. Doctors have identified several genetic risk factors for pulmonary emphysema, which may lead to earlier or more severe disease than usual. People with a strong family history or early-onset disease may benefit from a genetics discussion. In some cases, genetic testing can give a clearer picture of your personal risk.
Alpha-1 deficiency: A rare inherited lack of alpha-1 antitrypsin reduces the lungs’ protection against enzyme damage. This raises the chance of pulmonary emphysema, sometimes at a younger age.
Carrier states: Having one changed alpha-1 gene can lower protein levels slightly. This can modestly increase emphysema risk, but the degree of risk varies by the exact variant.
Telomere gene changes: Inherited changes that shorten telomeres can make lung tissue age faster. This may contribute to emphysema, sometimes alongside lung scarring.
Elastic fiber genes: Changes in elastin or related connective-tissue genes can weaken the lung’s supportive framework. This can cause early, more severe emphysema, occasionally with loose skin features in some families.
Family history: Emphysema that affects close relatives, especially at younger ages, suggests an inherited component. Multiple small genetic changes together can raise baseline risk for pulmonary emphysema.
Lifestyle risk factors
Pulmonary emphysema is largely shaped by daily habits, especially those that irritate or inflame the airways. The most important lifestyle risk factors for pulmonary emphysema involve inhaled substances and activity patterns that affect lung function. Nutrition and fitness choices can influence symptom burden, exacerbation risk, and disease progression. Addressing these behaviors can slow decline in breathing and improve quality of life.
Regular cigarette use injures and destroys alveoli, accelerating emphysema development. Quitting at any stage slows lung function decline and reduces flare-ups.
Aerosols can inflame and damage airway and alveolar tissue, potentially worsening emphysema. Avoiding vaping may reduce cough, wheeze, and exacerbations.
Combustion smoke from cannabis or waterpipe exposes lungs to irritants and toxins that harm alveoli. Cutting back or stopping can ease breathlessness and reduce chronic bronchitis symptoms.
Smoking or inhaling substances like cocaine or methamphetamine injures airway lining and impairs gas exchange. Avoidance lowers the risk of rapid symptom progression.
Risk prevention
Pulmonary emphysema risk can be lowered by protecting your lungs every day and staying ahead of infections. Prevention can mean both medical steps, like vaccines, and lifestyle steps, like exercise. Knowing early symptoms of pulmonary emphysema can prompt faster testing and treatment. Small changes add up over time and help you breathe easier for longer.
Stopping smoking is the single most effective way to prevent pulmonary emphysema. Quitting at any age slows lung damage.
Keep indoor spaces smoke-free at home and in the car. Even short exposures can irritate and injure airways over time.
Check local air quality and limit outdoor activity on high‑pollution days. Use high‑efficiency home air filters and ventilate kitchens when cooking.
If you’re around dust, fumes, or chemicals, wear proper masks or respirators and follow safety rules. Good ventilation and regular breaks away from exposure help protect lungs.
Transmission
Pulmonary emphysema isn’t contagious—you can’t catch it from coughs, kisses, sharing utensils, or the air in a room. It develops over years, most often from smoking and sometimes from long-term exposure to polluted air or workplace dusts and fumes.
Emphysema itself is not inherited, but a rare genetic problem called alpha‑1 antitrypsin deficiency can raise the chance; people who inherit it have low levels of a lung‑protecting protein and may develop earlier emphysema, especially if they smoke. If several relatives had early or unexplained emphysema, ask about testing for AAT deficiency and discuss how pulmonary emphysema is inherited in that setting.
When to test your genes
Consider genetic testing if emphysema appears at a young age (under 45), occurs in nonsmokers, runs in your family, or includes liver problems—these raise concern for alpha-1 antitrypsin deficiency. Testing can confirm the cause, guide inhalers and augmentation therapy, and prompt relatives to screen. Talk with a pulmonologist or genetic counselor.
Diagnosis
For many, the first step comes when everyday activities start feeling harder, like getting winded on a short walk or climbing a few stairs. Doctors usually begin by asking about breathing symptoms and exposures, then use a mix of breathing tests and scans to confirm or rule out emphysema. Many people find reassurance in knowing what their tests can—and can’t—show. Understanding how pulmonary emphysema is diagnosed can also clarify what treatments may help most right now.
Your provider asks when breathlessness and cough began, what triggers them, and how they affect daily life. They also review smoking and workplace exposures, past lung issues, and family history to guide how pulmonary emphysema is diagnosed.
Doctors listen to your lungs, check breathing pattern, and look for signs like using extra muscles to breathe. They may measure oxygen with a fingertip sensor during rest and activity.
You blow into a device that measures how fast and how much air you can exhale. Results showing airflow limitation that doesn’t fully improve with inhalers support a diagnosis of emphysema within COPD.
Spirometry is often repeated after an inhaled medicine that opens the airways. Limited improvement suggests fixed airflow limitation more consistent with emphysema than asthma.
Stages of Pulmonary emphysema
Pulmonary emphysema is usually staged using the same approach doctors use for COPD, based mainly on breathing test results and day‑to‑day impact. Early symptoms of pulmonary emphysema can be subtle—like getting winded on stairs or needing longer to catch your breath after a brisk walk—so testing helps place things on a clear scale. Many people feel relief once they understand what’s happening. Staging helps guide the right mix of inhalers, rehab, vaccines, and other care to keep you active and reduce flare‑ups.
Stage 1
Mild: You may have few or no symptoms, or just notice shortness of breath with hard exercise. Breathing tests are near normal (about 80% or more of expected). Staying active and avoiding smoke can make a big difference.
Stage 2
Moderate: Everyday activities like climbing a flight of stairs or carrying groceries can feel harder. Breathing tests show a moderate drop (about 50%–79% of expected). Inhalers and pulmonary rehab often help ease symptoms and improve stamina.
Stage 3
Severe: Shortness of breath is common with simple tasks, and flare‑ups may happen more often. Breathing tests show a larger drop (about 30%–49% of expected). Pulmonary emphysema at this stage often needs multiple medicines and close follow‑up.
Stage 4
Very severe: Breathing can be difficult even at rest, with low oxygen levels and frequent flare‑ups. Breathing tests are severely reduced (less than about 30% of expected). Oxygen therapy or advanced treatments may be discussed along with safety plans at home.
Outlook and prognosis
Daily routines often adapt with pulmonary emphysema—walking up stairs may take longer, errands might be spaced out, and colds can linger. The outlook is not the same for everyone, but stopping smoking, using inhalers correctly, and staying active can slow how quickly breathing declines. Doctors call this the prognosis—a medical word for likely outcomes. Early care can make a real difference, especially if you catch early symptoms of pulmonary emphysema such as a persistent morning cough, breathlessness on hills, or wheezing with colds.
Over time, most people find their exercise tolerance changes in steps rather than all at once, with flare-ups (exacerbations) driving many of those dips. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. People living with pulmonary emphysema often do better when they avoid lung irritants, get vaccinations, and treat infections quickly to prevent hospital stays. Some people experience frequent flare-ups and need oxygen, while others notice long stretches of stability with few setbacks.
Looking at the long-term picture can be helpful. Severe emphysema is linked with higher mortality, largely due to respiratory failure, heart strain, or infections, but many live for years—especially when they quit smoking, use the right medications, and stay engaged in pulmonary rehab. Knowing what to expect can ease some of the worry. Talk with your doctor about what your personal outlook might look like, including your lung function numbers, oxygen levels, and ways to reduce future flare-ups.
Long-term effects
Breathing may slowly become harder over years, which can limit walking, work, and social plans. Long-term effects vary widely, and they can change from month to month. With pulmonary emphysema, some people stay fairly stable for years, while others notice a gradual decline with occasional sudden flare-ups. Early symptoms of pulmonary emphysema often start with shortness of breath on stairs, and over time this can progress to breathlessness at rest.
Shortness of breath often progresses from during exercise to with daily tasks. Over years, some may feel winded even at rest. This can make outings and chores take longer.
Walking distance and stamina can shrink as lung elasticity declines. Many living with pulmonary emphysema find hills and stairs especially challenging. Recovery after activity may take longer than before.
A long-lasting cough can persist, sometimes with thick mucus. This may be worse in the morning or during cold seasons. Coughing fits can be tiring and interrupt conversations or sleep.
Periodic worsening of breathing, called exacerbations, can happen with infections or irritants. In pulmonary emphysema, these episodes may lead to urgent care visits or hospital stays. Repeated flare-ups can speed up long-term decline.
How is it to live with Pulmonary emphysema?
Living with pulmonary emphysema often means planning your day around your breath. Many notice they move slower, take breaks during simple tasks like showering or climbing a single flight of stairs, and keep inhalers or oxygen close by to prevent flare-ups. Crowded places, smoke, strong scents, or cold air can trigger coughing or breathlessness, so social plans and work may need adjusting; family and friends often step in with practical help and learn to spot early signs of a setback. With pulmonary rehab, pacing, vaccines, and smoke-free spaces, many people find a new rhythm that keeps them active and connected while protecting their energy.
Treatment and drugs
Pulmonary emphysema treatment focuses on easing breathlessness, preventing flare-ups, and helping you stay active. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as quitting smoking or vaping, pulmonary rehab, inhaled bronchodilators and steroids, vaccines to prevent lung infections, and oxygen therapy if your levels are low. For some people with pulmonary emphysema, surgery or minimally invasive procedures to reduce overinflated lung areas—or, rarely, lung transplant—may be considered when symptoms remain severe despite medicines. Alongside medical treatment, lifestyle choices play a role, including regular, paced exercise, good nutrition, breathing techniques, and keeping air quality in your home as clean as possible. Ask your doctor about the best starting point for you, and how to adjust your plan if symptoms or side effects change.
Non-drug treatment
Non-drug care for pulmonary emphysema focuses on easing breathlessness, building stamina, and protecting lung health. Alongside medicines, non-drug therapies can make daily activities feel more manageable. Recognizing early symptoms of pulmonary emphysema can help you start these measures sooner. Plans are tailored to your goals, fitness level, and whether symptoms change over time.
Stopping smoking slows lung damage and can reduce flare-ups. Counseling, quitlines, and planning for triggers help you stay quit. Loved ones avoiding smoke around you also protects your lungs.
Structured programs, like supervised exercise and education, can help improve stamina and reduce breathlessness. These courses also teach skills to manage day-to-day tasks more comfortably.
Methods such as pursed-lip and belly breathing help move air in and out more effectively. Practicing these during activity can lower the feeling of breathlessness.
Regular, moderate movement keeps muscles conditioned so they need less oxygen to work. Some strategies can slip naturally into your routine—like short, paced walks after meals. Interval-style exercise with rests can be easier to sustain.
Your genes may have an impact on how drugs work for you
Medicines for pulmonary emphysema can work differently based on your genes, which influence how quickly your body activates, breaks down, or transports a drug. These genetic differences can affect bronchodilator response, steroid benefit, side‑effects, and the best dose for you.
Pharmacological treatments
Treatment for pulmonary emphysema centers on inhaled medicines that open the airways and reduce inflammation, with add-on drugs to prevent flare-ups. When early symptoms of pulmonary emphysema are recognized, a tailored inhaler plan can ease breathlessness and cut urgent visits. Not everyone responds to the same medication in the same way. Your care team will match treatments to your symptoms, flare history, smoking status, and lung test results.
Albuterol or levalbuterol relax airway muscles within minutes for quick relief. Ipratropium may be added for extra benefit during breathlessness. Use before activity or as rescue as advised.
Salmeterol, formoterol, indacaterol, or olodaterol keep airways open for 12–24 hours. They are taken daily to ease symptoms and reduce flare-ups. Do not use them as rescue inhalers.
Tiotropium, umeclidinium, aclidinium, or glycopyrrolate reduce airway tightening and mucus. Daily use improves breathing and exercise tolerance. They can be used alone or with a LABA.
Fluticasone or budesonide may be added if you have frequent flare-ups. They are usually given in combination inhalers with a LABA to reduce exacerbations. Rinse your mouth after use to lower thrush risk.
Genetic influences
Most cases are driven by smoking and long-term exposure to air irritants, but genetics can also influence who develops pulmonary emphysema and how early it starts. The best-known inherited risk is alpha-1 antitrypsin deficiency, a condition where the body makes too little of a lung‑protecting protein; this can lead to emphysema at a younger age, especially in nonsmokers or light smokers. This condition is passed down in families when two altered copies of the gene are inherited, while carriers with one altered copy may have milder effects that become more important with smoking or dust exposure. Family history is one of the strongest clues to a genetic influence. If there is a family history of pulmonary emphysema, if it appears before age 45, or if it seems severe for the level of smoking, doctors may discuss testing for alpha‑1 antitrypsin deficiency and offer genetic counseling. Even when a gene is involved, lifestyle and environment still shape symptoms and progression, so stopping smoking and reducing exposures remain the most important steps.
Is Pulmonary emphysema genetic?
Genetics play a modest role in pulmonary emphysema. The strongest known cause is smoking, but rare inherited changes—most notably alpha-1 antitrypsin deficiency—can trigger early emphysema or worsen disease, especially without protection from smoke and occupational exposures.
Pharmacogenetics—how genetics influence drug effects
In pulmonary emphysema, your genes can influence which treatments are a good fit and how certain medicines behave in your body. The clearest example is alpha-1 antitrypsin deficiency; if testing confirms it, doctors may add alpha-1 antitrypsin infusions and tailor monitoring, and they may also discuss testing close relatives. For inhaled bronchodilators (like beta agonists and anticholinergics), small genetic differences in lung receptors may affect how much relief you feel or whether you notice tremor or a fast heartbeat, yet DNA testing to guide these inhalers isn’t routine today. With theophylline, genes that affect liver enzymes—and smoking status—can change how quickly the drug is cleared, so clinicians use blood level checks to fine-tune dosing rather than rely on genetic tests. How quickly your body breaks down nicotine can also steer quit‑smoking treatment; some clinics use a lab marker of nicotine metabolism to choose between nicotine replacement and medicines like varenicline, not a genetic report. Because pharmacogenetics in pulmonary emphysema is still developing, decisions about inhaled steroids or roflumilast lean more on your symptoms, past flare-ups, and blood eosinophil counts than on gene results. Not every difference in response is genetic, but other factors like age, other medicines, inhaler technique, and lung infections also play a big role.
Interactions with other conditions
Pulmonary emphysema often occurs alongside other lung problems, such as chronic bronchitis or asthma, and respiratory infections like flu or pneumonia can quickly turn a mild breathless day into a severe flare. Doctors call it a “comorbidity” when two conditions occur together. Heart and blood vessel disease is also more common in people with pulmonary emphysema, and lower oxygen levels can strain the right side of the heart or make existing heart failure worse. Conditions like acid reflux and obstructive sleep apnea may aggravate cough, chest tightness, and nighttime symptoms, which can make early symptoms of pulmonary emphysema easier to miss. There’s also a higher risk of lung infections and lung cancer, especially for those with a current or past smoking history. Share all your diagnoses and medicines with your care team so your treatment plan accounts for how these conditions interact.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described a slow, burdensome shortness of breath that made everyday tasks—walking a hill, carrying groceries—feel harder year by year. Long before lung scans, families noticed that some relatives developed a barrel-shaped chest, coughed in the mornings, and paused to catch their breath even in mild weather. Doctors listened with stethoscopes and heard a quietness where air should sound lively, noting that recovery from chest colds took longer than expected.
From early theories to modern research, the story of pulmonary emphysema moved from bedside observation to clear lung science. In the 19th century, autopsies showed lungs that were unusually large and over-inflated, with delicate air spaces stretched thin. Tobacco use was rising in Europe and the United States, coal smoke hung over cities, and dusty jobs were common—exposures that later proved important. Over time, descriptions became more precise: people with emphysema often felt breathless on exertion, then at rest; cough and mucus were frequent companions; chest shape and prolonged exhalation were features doctors could see and hear.
In the mid-20th century, as cigarette smoking peaked, emphysema and chronic bronchitis were grouped under chronic obstructive pulmonary disease (COPD). This shift helped clinicians study shared patterns: persistent airflow blockage, flare-ups with infections, and improvement with inhaled medicines and rehabilitation. Imaging advanced the picture. Chest X‑rays hinted at over-expanded lungs; later, CT scans showed that the tiny air sacs were damaged and merged into larger, less efficient spaces. Early symptoms of pulmonary emphysema—getting winded on stairs, wheezing after a cold—were recognized as signals to act sooner.
A key chapter opened with genetics. In the 1960s and 1970s, researchers linked severe, early-onset emphysema in some nonsmokers to a shortage of a protective protein, alpha‑1 antitrypsin. This explained why a minority developed lung damage in their 30s or 40s and showed that not all emphysema is caused by smoking alone. Advances in genetics confirmed that the protein acts like a shield for lung tissue; when it is low, ordinary inflammation can erode the air sacs more quickly. Awareness spread that secondhand smoke, indoor and outdoor air pollution, and workplace dusts also play roles, and that clean air policies matter for lung health.
In recent decades, knowledge has built on a long tradition of observation. Standardized definitions, spirometry to measure airflow, and modern treatments have made care more consistent across clinics. At the same time, clinicians now talk openly about variation: emphysema can be mild or advanced, centered in different parts of the lung, and influenced by smoking, environment, and biology. Understanding this history helps explain why prevention, early diagnosis, and tailored treatment are central to living well with pulmonary emphysema today.